知镜 Cognispect · 医学文献与研究工作台

The influence of LINC00511 and MDM2/MDM4 in lung carcinoma: Implications for immunological therapeutic strategies .

Zhang F, Li Q.
Pakistan journal of pharmaceutical sciences · 2026-11-01 · PMID 42631482

文献摘要

Background Immunotherapy has significantly improved the treatment of lung cancer, but some patients experience aggressive disease, the mechanisms of which remain unclear. In particular, the interaction between lncRNA and the MDM2/MDM4 pathway warrants in-depth exploration. Objectives This study aimed to investigate the role of LINC00511 in promoting aggressive disease during immunotherapy for lung carcinoma by modulating MDM2/MDM4 expression. Methods This study collected tissues from 30 lung cancer patients undergoing immunotherapy and used A549 cell lines. RT-PCR detected expression of LINC00511, while immunohistochemistry and immunofluorescence detected MDM2/MDM4 expression. Bioinformatics analysis and luciferase reporter assays were performed to confirm their relationship. Cell migration, invasion, proliferation and response to PD-1 inhibitors were assessed. Results using A549 cells and female BALB/c nude mice (n=6 per group). LINC00511 was significantly upregulated in aggressive disease tissues and positively correlated with tumor stage. MDM2/MDM4 expression was also elevated (P Conclusion LINC00511 promotes hyperprogressive disease in lung cancer during immunotherapy by upregulating MDM2/MDM4. Inhibition of LINC00511 effectively reverses tumor progression, suggesting a potential therapeutic target.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。